These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8621301)

  • 1. Adjuvant therapy for pathologic stage C prostate cancer: a casualty of the PSA revolution?
    Anscher MS
    Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):745-7. PubMed ID: 8621301
    [No Abstract]   [Full Text] [Related]  

  • 2. [Not Available].
    Bartkowiak D
    Aktuelle Urol; 2016 Feb; 47(1):22-4. PubMed ID: 26903117
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis.
    Gandaglia G; Boorjian SA; Parker WP; Zaffuto E; Fossati N; Bandini M; Dell'Oglio P; Suardi N; Montorsi F; Karnes RJ; Briganti A
    Eur Urol; 2017 Dec; 72(6):910-917. PubMed ID: 28622831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery?
    Keyser D; Kupelian PA; Zippe CD; Levin HS; Klein EA
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):723-9. PubMed ID: 9240638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment for cancer specifically diagnosed in high-aged population, prostate cancer].
    Miki T
    Nihon Ronen Igakkai Zasshi; 2006 Jan; 43(1):71-3. PubMed ID: 16521807
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of serum prostate-specific antigen levels after postoperative radiation therapy for pathologic stage T3, N0 prostate cancer.
    Buskirk SJ; Schild SE; Durr ED; Robinow JS; Bock FF; Wolfe JT; Tomera KM; Ferrigni RG
    Mayo Clin Proc; 1996 Mar; 71(3):242-8. PubMed ID: 8594281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?
    Choo R; Hruby G; Hong J; Hong E; DeBoer G; Danjoux C; Morton G; Klotz L; Bhak E; Flavin A
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):674-80. PubMed ID: 11849789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum prostate-specific antigen and Gleason grade as predictors of pathologic stage in clinically organ confined prostate cancer: implications for the choice of primary treatment.
    Ennis RD; Flynn SD; Fischer DB; Peschel RE
    Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):317-22. PubMed ID: 7523342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Adverse Pathology and Undetectable Ultrasensitive Prostate-Specific Antigen after Radical Prostatectomy: Is Adjuvant Radiation Warranted?
    Taneja SS
    J Urol; 2015 Dec; 194(6):1631-2. PubMed ID: 26582665
    [No Abstract]   [Full Text] [Related]  

  • 12. Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy.
    Thomas J; Gupta M; Grasso Y; Reddy CA; Heston WD; Zippe C; Dreicer R; Kupelian PA; Brainard J; Levin HS; Klein EA
    J Clin Oncol; 2002 Aug; 20(15):3213-8. PubMed ID: 12149293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of stage A1 prostate cancer: the case for treatment.
    Bahnson RR
    Semin Urol; 1993 May; 11(2):54-7. PubMed ID: 7689739
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of biochemical recurrence and timing of radiotherapy in pT3a N0 prostate cancer with positive surgical margin : A single center experience.
    Hegemann NS; Morcinek S; Buchner A; Karl A; Stief C; Knüchel R; Corradini S; Li M; Belka C; Ganswindt U
    Strahlenther Onkol; 2016 Jul; 192(7):440-8. PubMed ID: 27272660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
    Kupelian PA; Katcher J; Levin HS; Klein EA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [pT3R1 prostate cancer : Immediate or delayed radiotherapy after radical prostatectomy?].
    Bottke D; Wiegel T
    Urologe A; 2008 Nov; 47(11):1431-5. PubMed ID: 18810383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy.
    Ghadjar P; Aebersold DM; Albrecht C; Böhmer D; Flentje M; Ganswindt U; Höcht S; Hölscher T; Sedlmayer F; Wenz F; Zips D; Wiegel T;
    Strahlenther Onkol; 2018 Jul; 194(7):619-626. PubMed ID: 29383406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.
    Lee HM; Solan MJ; Lupinacci P; Gomella LG; Valicenti RK
    Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate specific antigen doubling time after radical prostatectomy: effect of neoadjuvant androgen deprivation therapy.
    Rabbani F; Perrotti M; Bastar A; Fair WR
    J Urol; 1999 Mar; 161(3):847-52. PubMed ID: 10022699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PSA recurrence following radical prostatectomy and radiotherapy].
    Fichtner J
    Urologe A; 2006 Oct; 45(10):1255-6, 1258-9. PubMed ID: 17006700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.